Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 3 1Phase 1/2 1Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Mycosis Fungoides 2Lymphoma, T-Cell, Cutaneous 2Lymphoma 2Leukemia, Myeloid, Acute 2Triple Negative Breast Neoplasms 1Sezary Syndrome 1Recurrence 1Multiple Myeloma 1Lymphoma, Primary Cutaneous Anaplastic Large Cell 1Leukemia 1Carcinoma, Intraductal, Noninfiltrating 1Breast Neoplasms 1Breast Carcinoma In Situ 1Advanced, Malignant Aerodigestive Tract Tumor (Lung, Head and Neck and Esophagus) 1

Interventions

fludarabine phosphate 7Peripheral Blood Stem Cell Transplantation 7Cyclophosphamide 7Filgrastim 6Bortezomib 6tanespimycin 5Vorinostat 5Tacrolimus 5Radiotherapy 4Lenalidomide 4Gemcitabine 4fludarabine 3Whole-Body Irradiation 3Mycophenolic Acid 3Irinotecan 3Etoposide 3Dasatinib 3Bendamustine Hydrochloride 3romidepsin 2nelarabine 2laromustine 2entinostat 2devimistat 2bryostatin 1 2belinostat 2aldesleukin 2Vitamin B 12 2SUB1 protein, human 2Polymerase Chain Reaction 2Pharmacogenomic Testing 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Sezary Syndrome × Bexarotene × Clear all
NCT01134341 2019-12-18

Pralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma

Acrotech Biopharma Inc.

Phase 1 Completed
34 enrolled
DermatologicLymphoid

Mycosis Fungoides, Recurrence, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous, Lymphoma, Primary Cutaneous Anaplastic Large Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡